Aehr Test Systems (AEHR), based in Fremont, California, stands out as a key player in semiconductor test and burn-in equipment. The company focuses on solutions that test, burn-in, and stabilize devices at the wafer level, singulated die, and package part form factors. Its flagship products—the FOX-XP and FOX-P series systems, WaferPak contactors, and DiePak carriers—support high-throughput testing for cutting-edge semiconductors.
From what I see, Aehr's revenue model benefits from both system sales and high-margin recurring consumables like WaferPaks and DiePaks. It maintains a solid foothold in fast-growing areas such as silicon carbide (SiC) power devices for electric vehicles (EVs), gallium nitride (GaN), silicon photonics for data centers, and AI processors. This positioning in critical applications for AI infrastructure, EVs, and telecom has driven much of the recent stock movement, as demand for reliable, high-power semiconductors picks up.
In the last 30 days, AEHR stock climbed +63%, moving from a closing price of about $42 to $68. The path was volatile but trend-driven, with notable gains in early April tied to earnings and order news, including a 26% single-day spike on April 8.
Looking at the past quarter, shares advanced +160%, from roughly $26 to $68. This period showed steady uptrends with occasional dips, like in late March, but overall momentum built on a stream of positive developments in semiconductor testing.
The recent 30-day surge came after Aehr's fiscal third-quarter results on April 7, which posted record bookings of $37.2 million and a book-to-bill ratio over 3.5x, largely from AI and data center demand. A standout was a major silicon photonics order from a global networking leader for high-power FOX-XP systems aimed at hyperscale data center optical interconnects. Even with revenue at $10.3 million missing estimates due to shipment timing, the $50.9 million effective backlog drew strong investor interest.
Prior announcements, such as the March 31 follow-on order for AI optical I/O systems, added to the positive sentiment. Analyst moves like Lake Street raising its price target to $56 while keeping a Buy rating helped fuel the rally. In my view, sector tailwinds in AI semiconductor testing have overshadowed any softness in the EV market affecting SiC demand. I also checked this using Tickeron’s AI Screener to compare AEHR against peers in the industry.
The quarterly gain was built on a series of significant orders that underscore Aehr's importance in AI infrastructure. Highlights included a $14 million February order from a leading AI processor customer for FOX-XP systems, a February production win for Sonoma systems testing next-gen ASICs, and January's $5.5 million Sonoma orders for AI processors.
These AI and data center themes have largely eclipsed revenue dips from EV-related SiC weakness and technical delays. Institutional buying aligned with broader trends in high-performance computing and photonics, helping shares break out during the semiconductor recovery. The growing cumulative backlog points to solid long-term prospects in power semiconductors and telecom.
In my research, I often turn to Tickeron’s Trending AI Robots page, which highlights the platform's top-performing AI trading bots out of hundreds available. These bots scan thousands of tickers using strategies like trend-following, mean reversion, and momentum, across timeframes from intraday to long-term swings. They provide key metrics such as win rate, profit factor, and Sharpe ratio, with a focus on recent outperformance in volatile sectors like semiconductors. One thing that stands out is how these tools help refine analysis and automate decisions with data-driven insights—I've found them particularly useful for tracking momentum plays like AEHR.
Looking ahead, I'm watching the fiscal fourth-quarter earnings closely for updates on backlog conversion and margin recovery. Important trends include AI accelerator rollouts, silicon photonics growth in data centers, and potential SiC/GaN rebound as EV demand stabilizes. Broader factors like interest rates and chip supply chains could sway hyperscaler spending.
Positive developments might come from ramped Sonoma production capacity—now over 20 systems per month—and new qualifications in memory or power semis. Risks remain, including order variability, competition from companies like TER, and meeting guidance. Much of the sentiment will depend on returning to non-GAAP profitability in Q4 fiscal 2026.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full Disclaimers and Limitations.
Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where AEHR advanced for three days, in of 274 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Momentum Indicator moved above the 0 level on May 08, 2026. You may want to consider a long position or call options on AEHR as a result. In of 83 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 238 cases where AEHR Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The 10-day RSI Indicator for AEHR moved out of overbought territory on April 27, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 45 similar instances where the indicator moved out of overbought territory. In of the 45 cases, the stock moved lower in the following days. This puts the odds of a move lower at .
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
The Moving Average Convergence Divergence Histogram (MACD) for AEHR turned negative on April 29, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 35 similar instances when the indicator turned negative. In of the 35 cases the stock turned lower in the days that followed. This puts the odds of success at .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where AEHR declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
AEHR broke above its upper Bollinger Band on May 11, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 54, placing this stock better than average.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. AEHR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (24.096) is normal, around the industry mean (20.574). P/E Ratio (19.449) is within average values for comparable stocks, (133.381). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.578). AEHR has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.006). P/S Ratio (70.922) is also within normal values, averaging (91.615).
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a manufacturer of burn-in and test equipment for semiconductor manufacturing
Industry ElectronicProductionEquipment